These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20967843)

  • 1. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.
    Dorfman R; Taylor C; Lin F; Sun L; Sandford A; Paré P; Berthiaume Y; Corey M; Durie P; Zielenski J;
    Pediatr Pulmonol; 2011 Apr; 46(4):385-92. PubMed ID: 20967843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
    Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.
    Blohmke CJ; Park J; Hirschfeld AF; Victor RE; Schneiderman J; Stefanowicz D; Chilvers MA; Durie PR; Corey M; Zielenski J; Dorfman R; Sandford AJ; Daley D; Turvey SE
    J Immunol; 2010 Dec; 185(12):7731-8. PubMed ID: 21068401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
    Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL;
    Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial concordance of phenotype and microbial variation among siblings with CF.
    Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
    Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathology of cystic fibrosis lung disease].
    Chinet T
    Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.
    Yarden J; Radojkovic D; De Boeck K; Macek M; Zemkova D; Vavrova V; Vlietinck R; Cassiman JJ; Cuppens H
    Thorax; 2005 Apr; 60(4):320-5. PubMed ID: 15790988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.
    Kraemer R; Baldwin DN; Ammann RA; Frey U; Gallati S
    Respir Res; 2006 Nov; 7(1):138. PubMed ID: 17137500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
    Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
    Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection.
    Park JE; Yung R; Stefanowicz D; Shumansky K; Akhabir L; Durie PR; Corey M; Zielenski J; Dorfman R; Daley D; Sandford AJ
    Genes Immun; 2011 Jul; 12(5):370-7. PubMed ID: 21270830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
    Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
    Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
    Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
    Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of deterioration of lung function in cystic fibrosis.
    Schaedel C; de Monestrol I; Hjelte L; Johannesson M; Kornfält R; Lindblad A; Strandvik B; Wahlgren L; Holmberg L
    Pediatr Pulmonol; 2002 Jun; 33(6):483-91. PubMed ID: 12001283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ENaCbeta and gamma genes as modifier genes in cystic fibrosis.
    Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T
    J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
    Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
    Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
    Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
    Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.